Posted Date : 07th Mar, 2025
Peer-Reviewed Journals List: A Guide to Quality Research Publications ...
Posted Date : 07th Mar, 2025
Choosing the right journal is crucial for successful publication. Cons...
Posted Date : 27th Feb, 2025
Why Peer-Reviewed Journals Matter Quality Control: The peer revie...
Posted Date : 27th Feb, 2025
The Peer Review Process The peer review process typically follows sev...
Posted Date : 27th Feb, 2025
What Are Peer-Reviewed Journals? A peer-reviewed journal is a publica...
Sulbactam and Durlobactam: An Analytical Perspective on Β-Lactamase Inhibition and Resistance Management
Author Name : Krishnaphanisri Ponnekanti, Addanki Anusha, B. Raj Kamal, Maddikunta Srilekha
ABSTRACT Sulbactam irreversibly inhibits the hydrolytic activity of β-lactamases. This compound is commercially available in combination with either ampicillin or cefoperazone. One of the particular advantages of using sulbactam containing combinations is that sulbactam itself has inherent activity against some Acinetobacter baumannii. Sulbactam is a first generation β-lactamase inhibitor with activity limited to a subset of class A enzymes that also has direct-acting antibacterial activity against Acinetobacter spp. Durlobactam is a new member of the diazabicyclooctane class of β-lactamase inhibitors with broad spectrum activity against Ambler class A, C, and D serine β-lactamases .